IFNA1 and COVID-19: Nonetheless, enhanced IFNA1 and a suppressed IL12p40 response strongly associated with persistent and overt inflammatory responses were detected even in a proportion of moderate pneumonia patients (8.3%, MG2) and in more than half (59.4%, SG2) of severe COVID-19 patients.